Works about RAS oncogenes


Results: 2033
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma.

    Published in:
    NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00505-0
    By:
    • Yousef, Abdelrahman;
    • Yousef, Mahmoud;
    • Chowdhury, Saikat;
    • Abdilleh, Kawther;
    • Knafl, Mark;
    • Edelkamp, Paul;
    • Alfaro-Munoz, Kristin;
    • Chacko, Ray;
    • Peterson, Jennifer;
    • Smaglo, Brandon G.;
    • Wolff, Robert A.;
    • Pant, Shubham;
    • Lee, Michael S.;
    • Willis, Jason;
    • Overman, Michael;
    • Doss, Sudheer;
    • Matrisian, Lynn;
    • Hurd, Mark W.;
    • Snyder, Rebecca;
    • Katz, Matthew H. G.
    Publication type:
    Article
    23

    Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma.

    Published in:
    NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00505-0
    By:
    • Yousef, Abdelrahman;
    • Yousef, Mahmoud;
    • Chowdhury, Saikat;
    • Abdilleh, Kawther;
    • Knafl, Mark;
    • Edelkamp, Paul;
    • Alfaro-Munoz, Kristin;
    • Chacko, Ray;
    • Peterson, Jennifer;
    • Smaglo, Brandon G.;
    • Wolff, Robert A.;
    • Pant, Shubham;
    • Lee, Michael S.;
    • Willis, Jason;
    • Overman, Michael;
    • Doss, Sudheer;
    • Matrisian, Lynn;
    • Hurd, Mark W.;
    • Snyder, Rebecca;
    • Katz, Matthew H. G.
    Publication type:
    Article
    24
    25

    Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumors.

    Published in:
    NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00334-z
    By:
    • Lee, Jessica K.;
    • Sivakumar, Smruthy;
    • Schrock, Alexa B.;
    • Madison, Russell;
    • Fabrizio, David;
    • Gjoerup, Ole;
    • Ross, Jeffrey S.;
    • Frampton, Garrett M.;
    • Napalkov, Pavel;
    • Montesion, Meagan;
    • Schutzman, Jennifer L.;
    • Ye, Xin;
    • Hegde, Priti S.;
    • Nagasaka, Misako;
    • Oxnard, Geoffrey R.;
    • Sokol, Ethan S.;
    • Ou, Sai-Hong Ignatius;
    • Shi, Zhen
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    41
    42
    43
    44

    EMMPRIN/CD147 is an independent prognostic biomarker in cutaneous melanoma.

    Published in:
    Experimental Dermatology, 2016, v. 25, n. 8, p. 618, doi. 10.1111/exd.13022
    By:
    • Caudron, Anne;
    • Battistella, Maxime;
    • Feugeas, Jean‐Paul;
    • Pages, Cécile;
    • Basset‐Seguin, Nicole;
    • Mazouz Dorval, Sarra;
    • Funck Brentano, Elisa;
    • Sadoux, Aurélie;
    • Podgorniak, Marie‐Pierre;
    • Menashi, Suzanne;
    • Janin, Anne;
    • Lebbé, Céleste;
    • Mourah, Samia
    Publication type:
    Article
    45
    46
    47
    48
    49
    50